Fast-Track Cities 2021 will be hosted March 22-25, 2021, in Lisbon.
Organized by the International Association of Providers of AIDS Care (IAPAC), in collaboration with the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Fast-Track Cities Institute, and other partners, the conference will take place at the Feira Internacional de Lisboa (Lisbon Exhibition and Congress Centre), otherwise known as the “FIL.”
The conference’s aim is to highlight successes achieved across the Fast-Track Cities network, address cross-cutting challenges faced by local stakeholders, and share best practices in accelerating urban HIV, TB, HBV, and HCV responses. In addition, the conference organizers have included COVID-19 among the conference program foci.
The first day (March 22, 2021) will be comprised of pre-conference events. The formal conference will take place March 23-25, 2021. The conference program will feature plenary sessions, panel discussions, skills-building workshops, oral abstract sessions, and poster sessions. The program will be announced by August 1, 2020.
EXHIBITOR AND SPONSORSHIP INFORMATION
Fast-Track Cities 2021 provides the opportunity to meet with elected officials, public health department representatives, clinical/public health researchers, healthcare payors, donors/grantors, clinicians, service providers, and civil society advocates from current and prospective Fast-Track Cities. There are a limited number of exhibitor and symposia spaces and sponsorship opportunities available for this conference. View the Fast-Track Cities 2021 Exhibitor and Sponsorship Prospectus here.
Following are key dates related to registration, abstract submission, and booking discounted hotel accommodations:
- Early Registration Deadline – November 6, 2020
- Standard Registration Deadline – January 8, 2021
- Abstract Submission Deadline – October 30, 2020
- Abstract Disposition Announcements – December 18, 2020
- Cancellation Deadline (with $75 penalty) – February 5, 2021
The COVID-19 pandemic has created numerous challenges for all of us, including individuals who are engaged in urban health responses, many of whom are contending with constrained budgets.
In the spirit of solidarity, IAPAC is eliminating registration fees for the Fast-Track Cities 2021 conference. In exchange, IAPAC requests that delegates book their accommodations within our discounted rooming block. Doing so will safeguard IAPAC by eliminating costly attrition penalties.
Note that delegates who elect to book their accommodations outside of our discounted hotel room block will be invoiced for the registration fee. Details regarding the discounted hotel room block will be announced in August 2020.
*Check this list to determine which registration type is appropriate based on your country of residence.
Registration fees are listed in US Dollars and apply to payments received prior to above stated deadlines.
- Participation in all conference events, including pre-conference
- Conference printed materials (e.g., Program and Abstracts book)
- Access to Fast-Track Cities 2021 conference app
- Refreshments during morning and afternoon breaks
- Fast-Track Cities 2021 newsletter prior to and during the conference
Fast-Track Cities 2021 is made possible through commercial sponsorships and educational grants from Gilead Sciences; Janssen Therapeutics; Merck, Sharpe & Dohme; and ViiV Healthcare. Additional commercial sponsorship and grant applications are pending.
The Fast-Track Cities 2021 program will include plenary sessions, panel discussions, skills-building workshops, oral abstract sessions, and poster sessions.
The conference’s aim is to highlight successes achieved across the Fast-Track Cities network, address cross-cutting challenges faced by local stakeholders, and share best practices in accelerating urban HIV, TB, and HCV responses.
The Fast-Track Cities 2021 program will be announced in August 2020.
Venue and Accommodations
The Fast-Track Cities 2021 venue will be the Feira Internacional de Lisboa (Lisbon Exhibition and Congress Centre), otherwise known as the “FIL,” which is located at Parque das Nações.
IAPAC is securing a discounted hotel room block within walking distance of the venue. An announcement will be forthcoming in August 2020.
Submit an Abstract
Abstracts that were submitted for presentation at the now re-purposed Virtual Fast-Track Cities 2020 conference (which will not include abstract sessions) may be considered for presentation at the in-person Fast-Track Cities 2021 conference that will be held March 23-25, 2021, in Lisbon.
The abstract submission portal has been re-opened. If you wish to update or withdraw your previously submitted abstract, you can do so by logging in to your dashboard on the IAPAC website. The new deadline for abstract submission is October 30, 2020. Abstract dispositions will be announced by December 18, 2020.
If you have not yet submitted an abstract and wish to do so for the Fast-Track Cities 2021 conference, the conference organizers are encouraging abstract submissions across multiple types of research domains, including:
- Behavioral science
- Clinical research
- Community participatory research
- Health economics
- Implementation science
- Operational research
- Public policy
Abstracts accepted for presentation at Fast-Track Cities 2021 will be presented during the conference’s oral abstract sessions or poster sessions. Abstracts must be submitted online by October 30, 2020.
Following are key dates relevant to abstract submissions:
- Abstract Submission Deadline – October 30, 2020
- Abstract Disposition Announcements – December 18, 2020
- Deadline to Withdraw Abstract/Change Presenting Author – February 5, 2021
CALL FOR ABSTRACTS
As noted above, abstract submissions are encouraged in a wide variety of specific domains, including:
- Behavioral Science
- Clinical Research
- Community Participatory Research
- Health Economics
- Implementation Science
- Operational Research
- Public Policy
Within these domains we encourage abstracts across the following tracks:
- Diagnostic Approaches
- Differentiated Service Delivery
- Public-Private Partnerships
- Cross-Border Collaborations
- Continuity of Care (HIV)
- Continuity of Care (TB)
- Continuity of Care (HCV)
- Continuity of Care (Syndemic Conditions)
- Diagnostic and monitoring tools
- Antiretroviral therapy in adults
- Comorbidities associated with HIV
- Clinical issues specific to gender
- Clinical issues specific to pediatric/adolescent HIV
- Clinical issues specific to key populations
- Treatment as prevention
- Combination HIV prevention
- Behavioral science research
- Social science research
- External/social stigma
- Internalized stigma
- Intersectional stigma
- Economic, food, and housing security
- Mental and spiritual health
- Health-related quality of life
- Data generation/analysis/monitoring/measurement strategies
- Intervention development, implementation, and outcomes
- Dissemination/implementation of evidence-based approaches
- Uptake and impact of innovative approaches
- Operations research and demonstration projects
- Health policy advocacy, implementation, financing, outcomes
- Resource, structural, and service delivery issues and innovations
- Ethical, legal, political, and societal drivers and responses
- Political and parliamentarian engagement
- Clinical and service provider engagement
- Community and civil society engagement
- Donor/grantor engagement
- Partnership frameworks and models
Particularly as applied to key and disproportionately affected populations:
- Treatment naïve, treatment experienced
- Individuals living with mental health challenges
- Individuals living with HIV and comorbidities (i.e., HCV, TB)
- Men who have sex with men
- Transgender individuals
- Women in high incidence areas
- Pregnant women, women of childbearing age
- Children and adolescents
- Migrants and displaced populations
- Female and male sex workers
- People who use drugs
- Incarcerated or recently released individuals
Abstracts must be submitted online by 5 pm ET, October 30, 2020. Submitted abstracts will be considered for oral and poster presentations. Submitted abstracts should report information not previously published, or intended to be published, prior to February 5, 2021.
It is the responsibility of the presenting author to ensure accuracy of content, spelling, and presentation. Abstracts will be published as submitted, subject to reformatting that may be required by IAPAC.
Abstract contents will be either research-based data using established scientific methods or demonstrate experience and information from individuals or institutions working in the field. Please follow one of two structured formats (A or B), indicating in bold the four parts of your abstract:
Format A: Data-Driven Abstracts
- Background: a concise statement of the issues evaluated
- Methods: the investigational model used
- Results: specific findings
- Conclusions: summary of findings, supported by results
Format B: Program Descriptions and Case Studies
- Introduction: a concise statement of the issues addressed
- Description: a description of the project, case study, experience, or intervention
- Lessons Learned: project results, implementation issues, and/or case study solutions
- Recommendations: further recommendations or next steps
Following are some general guidelines for individuals interested in submitting an abstract(s):
- The abstract must NOT contain more than 300 words.
- Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
- Literature references and acknowledgements should not form any part of the abstract’s content. Figures and tables are acceptable.
- The author is responsible for all grammatical and factual details. You may edit your abstract after it has been submitted.
- All abstracts must be submitted in English. If you are not fluent in English, please attempt to have your abstract reviewed by a fluent English speaker.
- The interdisciplinary nature of the conference delegates should be kept in mind when writing the abstract; thus sub-specialty jargon should be avoided.
- Define all abbreviations and concepts in your abstract at first use.
- For therapeutic agents, only generic names may be used (trade names are not permitted).
ABSTRACT SUBMISSION AND ACCEPTANCE
All abstracts must be submitted online no later than 5 pm ET, October 30, 2020. All submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.
Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book and during the Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than December 18, 2020. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).
Accepted abstracts will be in one of two categories:
- Oral Abstract presentation
- Poster Abstract presentation
Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the Poster Session. Oral abstract and poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.
Please note that only the abstracts of paid conference registrants will be included in the final Program and Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish, and online posting, if accepted. A copy of any electronic presentation and handouts will be transferred to IAPAC.
All submissions must be received online by 5 pm ET, October 30, 2020. It is strongly recommended that you do not wait until the last minute to submit your abstract(s). You may review/edit submissions from now until 5 pm ET, February 5, 2021. Abstracts may be withdrawn or the presenter may be changed until February 5, 2021.Login or Register to submit an abstract